Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA recognition elements (MREs) are specific nucleotide sequences, primarily located within the 3' untranslated regions (3'-UTRs) of messenger RNAs (mRNAs), that serve as the binding sites for microRNAs (miRNAs) (Bartel, 2009). These elements are central to post-transcriptional gene regulation, where the binding of a miRNA-loaded RNA-induced silencing complex (miRISC) typically results in translational repression or mRNA degradation (Jonas & Izaurralde, 2015). A single mRNA transcript often contains multiple MREs, allowing for complex, combinatorial regulation by multiple miRNAs, a phenomenon often exploited by competing endogenous RNAs (ceRNAs) that act as 'sponges' to sequester miRNAs (Helwak et al., 2013). In various diseases, such as cancer and viral infections, the interaction between miRNAs and MREs is frequently dysregulated, leading to the aberrant expression of oncogenes or the stabilization of viral genomes (Gebert & MacRae, 2019). Therapeutic intervention targeting these elements involves the use of antisense oligonucleotides known as 'target site blockers' (TSBs), which physically occupy the MRE to prevent miRNA binding and restore target gene expression (Stenvang et al., 2012). This approach provides a high level of specificity, enabling the modulation of a single miRNA-mRNA interaction without affecting the broader regulatory network of the miRNA.
Steric inhibition of microRNA binding to the 3'-UTR of target mRNA transcripts, preventing the microRNA-induced silencing complex (miRISC) from initiating mRNA degradation or translational repression.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA recognition element (MRE).